Endothelial actions of atrial natriuretic peptide prevent pulmonary hypertension in mice
Autor: | Ralph T. Schermuly, Kai Schuh, Michaela Kuhn, Marco Abeßer, Hideo A. Baba, Bhola K. Dahal, Baktybek Kojonazarov, Katharina Völker, Franziska Werner, Birgit Gaßner |
---|---|
Rok vydání: | 2016 |
Předmět: |
0301 basic medicine
medicine.medical_specialty Endothelium Physiology Hypertension Pulmonary Medizin Vasodilation Peptidyl-Dipeptidase A 030204 cardiovascular system & hematology Pulmonary hypertension Vascular remodelling in the embryo Mice 03 medical and health sciences 0302 clinical medicine Guanylyl cyclase-A Atrial natriuretic peptide Physiology (medical) Internal medicine medicine Animals ddc:610 Hypoxia Lung Cyclic GMP Mice Knockout Endothelin-1 biology Angiotensin II Endothelial Cells Angiotensin-converting enzyme Original Contribution Hypoxia (medical) medicine.disease 030104 developmental biology medicine.anatomical_structure Endocrinology biology.protein medicine.symptom Cardiology and Cardiovascular Medicine Receptors Atrial Natriuretic Factor Atrial Natriuretic Factor |
Zdroj: | Basic Research in Cardiology |
ISSN: | 1435-1803 0300-8428 |
Popis: | The cardiac hormone atrial natriuretic peptide (ANP) regulates systemic and pulmonary arterial blood pressure by activation of its cyclic GMP-producing guanylyl cyclase-A (GC-A) receptor. In the lung, these hypotensive effects were mainly attributed to smooth muscle-mediated vasodilatation. It is unknown whether pulmonary endothelial cells participate in the homeostatic actions of ANP. Therefore, we analyzed GC-A/cGMP signalling in lung endothelial cells and the cause and functional impact of lung endothelial GC-A dysfunction. Western blot and cGMP determinations showed that cultured human and murine pulmonary endothelial cells exhibit prominent GC-A expression and activity which were markedly blunted by hypoxia, a condition known to trigger pulmonary hypertension (PH). To elucidate the consequences of impaired endothelial ANP signalling, we studied mice with genetic endothelial cell-restricted ablation of the GC-A receptor (EC GC-A KO). Notably, EC GC-A KO mice exhibit PH already under resting, normoxic conditions, with enhanced muscularization of small arteries and perivascular infiltration of inflammatory cells. These alterations were aggravated on exposure of mice to chronic hypoxia. Lung endothelial GC-A dysfunction was associated with enhanced expression of angiotensin converting enzyme (ACE) and increased pulmonary levels of Angiotensin II. Angiotensin II/AT1-blockade with losartan reversed pulmonary vascular remodelling and perivascular inflammation of EC GC-A KO mice, and prevented their increment by chronic hypoxia. This experimental study indicates that endothelial effects of ANP are critical to prevent pulmonary vascular remodelling and PH. Chronic endothelial ANP/GC-A dysfunction, e.g. provoked by hypoxia, is associated with activation of the ACE–angiotensin pathway in the lung and PH. |
Databáze: | OpenAIRE |
Externí odkaz: |